Trials / Unknown
UnknownNCT00905008
Long-Term Safety of Drug Eluting Stents in the "Real World" (FReIburger STent Registry)
Long-Term Safety and Efficacy of Drug Eluting Stents in "Real World" - Results From the FReIburger STent Registry
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,502 (actual)
- Sponsor
- University Hospital Freiburg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The FReIburger STent Registry (FRIST) is designed to determine the long term safety and efficacy of Drug Eluting Stents (DES) in a "real-world" patient population requiring stent implantation. FRIST included patients treated with DES and bare-metal stents (BMS) in the University Hospital of Freiburg, Germany, according to a non-restrictive inclusion criterion, in which virtually all consecutive patient subsets were considered eligible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | transluminal percutaneous coronary intervention | All interventions were done according to current practice guidelines. The operator was responsible for the decision to choose a specific treatment strategy. Angiographic success was defined as residual stenosis \<30% by visual analysis in the presence of TIMI 3 flow grade. The patients were prescribed aspirin plus clopidogrel 75 mg per day, after a loading dose of 300 mg or 600 mg, before or during the index coronary intervention. After procedure, all patients were advised to maintain lifelong use of aspirin. The use of clopidogrel (75 mg per day) was always adapted according to guideline recommendations. Heparin was infused throughout the procedure to maintain an activated clotting time of at least 250 sec. The administration of platelet glycoprotein IIb/IIIa receptor blocker was encouraged, unless in existing contraindications. |
| DEVICE | Drug-Eluting and Bare-Metal stents | Sirolimus-eluting stents (Cypher®), Paclitaxel-eluting stents (Taxus®) Zotarolimus-eluting stents (Endeavor®) and uncoated (bare-metal) stents |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2009-05-01
- First posted
- 2009-05-20
- Last updated
- 2009-05-20
Source: ClinicalTrials.gov record NCT00905008. Inclusion in this directory is not an endorsement.